SE426782B - Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter - Google Patents

Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter

Info

Publication number
SE426782B
SE426782B SE7605841A SE7605841A SE426782B SE 426782 B SE426782 B SE 426782B SE 7605841 A SE7605841 A SE 7605841A SE 7605841 A SE7605841 A SE 7605841A SE 426782 B SE426782 B SE 426782B
Authority
SE
Sweden
Prior art keywords
alkaloids
hydrated
salts
synthetic derivatives
make stable
Prior art date
Application number
SE7605841A
Other languages
English (en)
Swedish (sv)
Other versions
SE7605841L (sv
Inventor
L Ehrhardt
L Patt
V Hartmann
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE7605841L publication Critical patent/SE7605841L/
Publication of SE426782B publication Critical patent/SE426782B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
SE7605841A 1975-05-31 1976-05-24 Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter SE426782B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2524184 1975-05-31

Publications (2)

Publication Number Publication Date
SE7605841L SE7605841L (sv) 1976-12-01
SE426782B true SE426782B (sv) 1983-02-14

Family

ID=5947910

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7605841A SE426782B (sv) 1975-05-31 1976-05-24 Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter

Country Status (26)

Country Link
JP (1) JPS585167B2 (fr)
AT (1) AT355725B (fr)
AU (1) AU508625B2 (fr)
BE (1) BE842348A (fr)
CA (1) CA1069438A (fr)
CS (1) CS205023B2 (fr)
DD (1) DD125597A5 (fr)
DK (1) DK154606C (fr)
ES (1) ES448372A1 (fr)
FI (1) FI761461A (fr)
FR (1) FR2313059A1 (fr)
GB (1) GB1539083A (fr)
GR (1) GR60264B (fr)
HK (1) HK15383A (fr)
HU (1) HU171514B (fr)
IE (1) IE42999B1 (fr)
IL (1) IL49668A (fr)
MY (1) MY8300013A (fr)
NL (1) NL172616C (fr)
NO (1) NO145262C (fr)
NZ (1) NZ180984A (fr)
PT (1) PT65151B (fr)
SE (1) SE426782B (fr)
SU (2) SU952106A3 (fr)
YU (1) YU133076A (fr)
ZA (1) ZA763138B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2935515A1 (de) * 1979-09-03 1981-03-19 Fa. Dr. Willmar Schwabe, 7500 Karlsruhe Arzneipraeparat
FR2483235A1 (fr) * 1980-05-28 1981-12-04 Fabre Sa Pierre Compositions a usage topique contenant des alcaloides de l'ergot de seigle et de vinca rosea destinees au traitement des hyperseborrhees
DE3227122A1 (de) * 1982-07-20 1984-01-26 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Stabile loesungen von mutterkornalkaloiden
HU192050B (en) * 1983-04-22 1987-05-28 Sandoz Ag Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist
IT1200609B (it) * 1985-04-04 1989-01-27 Poli Ind Chimica Spa Composizione farmaceutice per il trattamento delle turbe cerebrovascolari e del cervello anziano
DE102007014947B4 (de) 2007-03-23 2010-05-27 Axxonis Pharma Ag Stabilisierte wässrige Lösungen von Ergolinverbindungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD43402A (fr) *
US2033921A (en) * 1931-08-28 1936-03-17 Squibb & Sons Inc Solution of ergot alkaloids
US1969382A (en) * 1932-05-21 1934-08-07 Squibb & Sons Inc Preparation of a stable hydro-alcoholic extract of ergot

Also Published As

Publication number Publication date
IL49668A (en) 1979-10-31
SE7605841L (sv) 1976-12-01
AU1442276A (en) 1977-12-01
ATA390476A (de) 1979-08-15
BE842348A (fr) 1976-11-29
PT65151B (fr) 1978-02-06
NO145262C (no) 1982-02-17
NO145262B (no) 1981-11-09
JPS51144720A (en) 1976-12-13
NL172616B (nl) 1983-05-02
ZA763138B (en) 1978-01-25
IE42999L (en) 1976-11-30
IL49668A0 (en) 1976-09-30
MY8300013A (en) 1983-12-31
DK228676A (da) 1976-12-01
FR2313059A1 (fr) 1976-12-31
PT65151A (fr) 1976-06-01
ES448372A1 (es) 1978-03-01
NZ180984A (en) 1978-06-20
AU508625B2 (en) 1980-03-27
NO761760L (fr) 1976-12-01
HK15383A (en) 1983-05-20
DK154606B (da) 1988-12-05
SU952106A3 (ru) 1982-08-15
NL172616C (nl) 1983-10-03
AT355725B (de) 1980-03-25
DD125597A5 (fr) 1977-05-04
NL7605745A (nl) 1976-12-02
CA1069438A (fr) 1980-01-08
HU171514B (hu) 1978-01-28
JPS585167B2 (ja) 1983-01-29
CS205023B2 (en) 1981-04-30
DK154606C (da) 1989-05-01
GR60264B (en) 1978-04-20
GB1539083A (en) 1979-01-24
IE42999B1 (en) 1980-12-03
FR2313059B1 (fr) 1978-12-15
FI761461A (fr) 1976-12-01
YU133076A (en) 1984-08-31
SU677664A3 (ru) 1979-07-30

Similar Documents

Publication Publication Date Title
SE419645B (sv) Sett att framstella 3-amino-indazolkarbonylsyra derivat
SE439485B (sv) Sett att framstella nya alkyloximderivat av 7-aminotiazolyl-acetamidocefalosporansyra
SE441528B (sv) Sett att framstella nya 3-kinolin-karboxylsyraderivat
SE420599B (sv) Sett att framstella farmakologiskt aktiva derivat av 4-hydroxi-2-pyrrolidon
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE434394B (sv) Analogiforfarande for framstellning av kinolonalkansyraderivat
SE7610422L (sv) Forfarande for framstellning av pyrimidinderivat
SE445923B (sv) Forfarande for framstellning av glukosaminderivat
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE431652B (sv) Forfarande for framstellning av 7beta-amino-3cefem-3ol-4-karboxylsyraderivat
SE427111B (sv) Sett att framstella pilokarpiniumsalter
SE417507B (sv) Sett att framstella 2-arylamino-2-imidazolinderivat
SE411752B (sv) Forfarande for framstellning av substituerade aminobensoesyraderivat
SE420602B (sv) Sett att framstella pyrazin-3-metoxi-2-karboxamidderivat
SE426782B (sv) Sett att framstella stabila losningar av hydrerade mjoldrygealkaloider, deras syntetiska derivat eller deras salter
SE434842B (sv) Sett att framstella nya 7-amino-tiazolyl-acetamido-cefalosporansyraderivat
SE413771B (sv) Sett att framstella nya derivat av 5h-dibebs(b,f)azepin
SE427655B (sv) Sett att framstella abietamidderivat
SE415653B (sv) Sett att framstella cykloalkylfenoxikarboxylsyraderivat
SE420731B (sv) Sett att framstella 5-androsten-17-on-derivat
SE412233B (sv) Sett att framstella nya fenotiazinderivat
SE428471B (sv) Sett att framstella imidazolderivat
SE7508779L (sv) Sett att framstella prostaninsyraderivat
SE7609666L (sv) Sett att framstella nya 5-aminometyltiazolderivat
SE412400B (sv) Sett att framstella salter av poly-alfa-hydroxiakrylsyror.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7605841-1

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7605841-1

Format of ref document f/p: F